Margalida Rotger

3.0k total citations
40 papers, 1.9k citations indexed

About

Margalida Rotger is a scholar working on Infectious Diseases, Virology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Margalida Rotger has authored 40 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 17 papers in Virology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Margalida Rotger's work include HIV/AIDS drug development and treatment (24 papers), HIV Research and Treatment (17 papers) and HIV/AIDS Research and Interventions (7 papers). Margalida Rotger is often cited by papers focused on HIV/AIDS drug development and treatment (24 papers), HIV Research and Treatment (17 papers) and HIV/AIDS Research and Interventions (7 papers). Margalida Rotger collaborates with scholars based in Switzerland, United States and Czechia. Margalida Rotger's co-authors include Amalio Telenti, Hansjakob Furrer, Laurent A. Décosterd, Sara Colombo, Huldrych F. Günthard, Thierry Buclin, Gabriela Bleiber, Matthias Cavassini, Chantal Csajka and Jérôme Biollaz and has published in prestigious journals such as Nature Communications, PLoS ONE and Hepatology.

In The Last Decade

Margalida Rotger

40 papers receiving 1.8k citations

Peers

Margalida Rotger
Gabriela Bleiber Switzerland
Larissa Wenning United States
Joseph M. Custodio United States
Margo Heath‐Chiozzi United States
Polina German United States
Cassy Workman Australia
N J Fitch United Kingdom
Gabriela Bleiber Switzerland
Margalida Rotger
Citations per year, relative to Margalida Rotger Margalida Rotger (= 1×) peers Gabriela Bleiber

Countries citing papers authored by Margalida Rotger

Since Specialization
Citations

This map shows the geographic impact of Margalida Rotger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margalida Rotger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margalida Rotger more than expected).

Fields of papers citing papers by Margalida Rotger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margalida Rotger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margalida Rotger. The network helps show where Margalida Rotger may publish in the future.

Co-authorship network of co-authors of Margalida Rotger

This figure shows the co-authorship network connecting the top 25 collaborators of Margalida Rotger. A scholar is included among the top collaborators of Margalida Rotger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margalida Rotger. Margalida Rotger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martínez‐Picado, Javier, Paul J. McLaren, Itziar Erkizia, et al.. (2016). Identification of Siglec-1 null individuals infected with HIV-1. Nature Communications. 7(1). 12412–12412. 23 indexed citations
2.
Aouri, Manel, Alice Panchaud, Margalida Rotger, et al.. (2016). Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals. Journal of Antimicrobial Chemotherapy. 71(7). 1933–1942. 14 indexed citations
3.
McLaren, Paul J., Jean Louis Raisaro, Manel Aouri, et al.. (2016). Privacy-preserving genomic testing in the clinic: a model using HIV treatment. Genetics in Medicine. 18(8). 814–822. 31 indexed citations
4.
Aouri, Manel, Matthias Cavassini, A Anagnostopoulos, et al.. (2015). In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal Fluid. Drug Metabolism and Disposition. 44(1). 151–161. 26 indexed citations
5.
Cummins, Nathan W., Jacqueline Neuhaus, Haitao Chu, et al.. (2015). Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis. EBioMedicine. 2(7). 706–712. 20 indexed citations
6.
Guidi, Monia, Mona Arab‐Alameddine, Margalida Rotger, et al.. (2012). Dosage Optimization of Treatments Using Population Pharmacokinetic Modeling and Simulation. CHIMIA International Journal for Chemistry. 66(5). 291–291. 7 indexed citations
7.
Dobrinas, Maria, Séverine Crettol, Beatrice Oneda, et al.. (2012). Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels. Pharmacogenetics and Genomics. 23(2). 84–93. 39 indexed citations
8.
Iulio, Julia di, Angela Ciuffi, Karen Fitzmaurice, et al.. (2011). Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance. Hepatology. 53(5). 1446–1454. 48 indexed citations
9.
Rotger, Margalida, Thomas Gsponer, Raquel Martínez, et al.. (2010). Impact of Single Nucleotide Polymorphisms and of Clinical Risk Factors on New‐Onset Diabetes Mellitus in HIV‐Infected Individuals. Clinical Infectious Diseases. 51(9). 1090–1098. 23 indexed citations
10.
Rotger, Margalida, Kristen K. Dang, Jacques Fellay, et al.. (2010). Genome-Wide mRNA Expression Correlates of Viral Control in CD4+ T-Cells from HIV-1-Infected Individuals. PLoS Pathogens. 6(2). e1000781–e1000781. 128 indexed citations
11.
Iulio, Julia di, Aurélie Fayet, Mona Arab‐Alameddine, et al.. (2009). In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function. Pharmacogenetics and Genomics. 19(4). 300–309. 120 indexed citations
12.
Rotger, Margalida, Patrick Taffé, Raquel Martínez, et al.. (2009). Contribution of Genome-Wide Significant Single-Nucleotide Polymorphisms and Antiretroviral Therapy to Dyslipidemia in HIV-Infected Individuals. Circulation Cardiovascular Genetics. 2(6). 621–628. 33 indexed citations
13.
Arab‐Alameddine, Mona, Julia di Iulio, Thierry Buclin, et al.. (2009). Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals. Clinical Pharmacology & Therapeutics. 85(5). 485–494. 99 indexed citations
14.
Colombo, Sara, Andri Rauch, Margalida Rotger, et al.. (2008). TheHCP5Single‐Nucleotide Polymorphism: A Simple Screening Tool for Prediction of Hypersensitivity Reaction to Abacavir. The Journal of Infectious Diseases. 198(6). 864–867. 70 indexed citations
15.
Rotger, Margalida, Heike Tegude, Sara Colombo, et al.. (2007). Predictive Value of Known and Novel Alleles of CYP2B6 for Efavirenz Plasma Concentrations in HIV-infected Individuals. Clinical Pharmacology & Therapeutics. 81(4). 557–566. 208 indexed citations
16.
Rotger, Margalida, Chantal Csajka, & Amalio Telenti. (2006). Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents. Current HIV/AIDS Reports. 3(3). 118–125. 29 indexed citations
17.
Colombo, Sara, Nicole Soranzo, Margalida Rotger, et al.. (2005). Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo. Pharmacogenetics and Genomics. 15(9). 599–608. 63 indexed citations
18.
Tarr, Philip, Patrick Taffé, Gabriela Bleiber, et al.. (2005). Modeling the Influence ofAPOC3, APOE,andTNFPolymorphisms on the Risk of Antiretroviral Therapy–Associated Lipid Disorders. The Journal of Infectious Diseases. 191(9). 1419–1426. 90 indexed citations
19.
Rotger, Margalida, Patrick Taffé, Gabriela Bleiber, et al.. (2005). Gilbert Syndrome and the Development of Antiretroviral Therapy–Associated Hyperbilirubinemia. The Journal of Infectious Diseases. 192(8). 1381–1386. 142 indexed citations
20.
Rotger, Margalida, et al.. (2004). Increasing incidence of imported schistosomiasis in Mallorca, Spain. European Journal of Clinical Microbiology & Infectious Diseases. 23(11). 855–856. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026